top of page

35+ YEARS IN MEDICAL DEVICE | PHARMACEUTICAL | BIOTECHNOLOGY | DIAGNOSTICS

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...

Executive Spotlights

Lesson’s Learned from Building out the Commercial Organization

SK Life Science breaks through Covid barriers to bring epilepsy drug to market

Lutronic’s Focus on Change during the Pandemic

From Big Pharma to Startup: What are the Challenges?

The View from Olympus: How This MedTech Leader Approached the Pandemic

DENTALEZ COO Heather Trombley on Reinvigorating the Company

Seqirus Exec on Vaccine Differentiation

Zimmer Biomet VP on Covering the Territory

How Teleflex Grew its Market Value 4x in 6 Years

Admedus COO David St. Denis on Courage, Commitment and Conversation

Search

Boston Scientific weighing deal to buy Shockwave Medical

gdelacruz57
Apr 26, 2023
1 min read

Marlborough, MA, April 21, 2023 (Reuters) -- Boston Scientific is exploring a deal to buy cardiovascular medical device company Shockwave Medical, Bloomberg News reported on Friday citing people with knowledge of the matter.

Read full article here.

Recent Posts

Wandercraft Raises $75M to Launch Self-Balancing Exoskeleton ‘Eve’ by 2026

New York, NY, June 12, 2025 (yahoo finance) -- Wandercraft has secured $75 million in Series D funding to support the market...

PolyActiva Raises $25M and Appoints New CEO to Accelerate U.S. Growth and Advance Ocular Drug Delivery Platform

Fort Worth, TX, June 18, 2025 (Business Wire) -- PolyActiva appointed Jerry St. Peter as CEO and raised $25 million in Series C funding...

Bristol Myers Commits $11.1B in Strategic Bet on BioNTech’s Next-Gen Cancer Immunotherapy

Princeton, NJ, June 2, 2025 (Reuters) -- Bristol Myers Squibb will pay up to $11.1 billion to co-develop BioNTech's next-generation...

Comments

Life Science Headlines

Wandercraft Raises $75M to Launch Self-Balancing Exoskeleton ‘Eve’ by 2026

PolyActiva Raises $25M and Appoints New CEO to Accelerate U.S. Growth and Advance Ocular Drug Delivery Platform

Bristol Myers Commits $11.1B in Strategic Bet on BioNTech’s Next-Gen Cancer Immunotherapy

New Leadership at Oncolytics Biotech: Jared Kelly Takes Helm as CEO to Accelerate Pelareorep Development

Lilly Acquires Verve Therapeutics in $1.3B Deal to Pioneer One-Time Gene Editing Therapies for Heart Disease

Neuralink Raises $650M as Clinical Trials Commence for Brain Implant Technology

NanoVibronix Names Doron Besser as CEO, Succeeding Brian Murphy

Eli Lilly Acquires SiteOne Therapeutics in $1B Deal to Bolster Non-Opioid Pain

PharmaLogic Names Etienne Montagut as President and CEO, Signaling New Growth Chapter in Radiopharmaceutical CDMO Sector

Sanofi Acquires Blueprint Medicines in $9.1B Deal, Bolstering Rare Immunology Pipeline

bottom of page